Provinal®
Commercial- Indications
- Hypercholesterolemia, Cardiovascular disease, Metabolic syndrome, Type 2 diabetes, Insulin resistance, Skin aging
Company intelligence / Profile preview
Tersus Life Sciences is a bio-life sciences company dedicated to the research, development, and commercialization of Provinal, a highly purified monounsaturated fatty acid known as Omega-7. The company focuses on the therapeutic potential of palmitoleic acid in addressing cardiovascular health, metabolic syndrome, and systemic inflammation. Their flagship product, Provinal, is uniquely processed to remove palmitic acid, thereby avoiding pro-inflammatory effects while maximizing heart-healthy benefits. Tersus supports its products through rigorous clinical research, including studies demonstrating significant reductions in C-reactive protein and improvements in lipid profiles. The company's offerings target the nutraceutical, functional food, and pharmaceutical ingredient markets globally. Headquartered in Florida, Tersus continues to expand the applications of Omega-7 into areas such as ocular health and glucose metabolism.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tersus Life Sciences.